+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Methylphenidate treatment for cocaine abusers with adult attention-deficit/hyperactivity disorder: a pilot study

Methylphenidate treatment for cocaine abusers with adult attention-deficit/hyperactivity disorder: a pilot study

Journal of Clinical Psychiatry 59(6): 300-305

Background: Attention-deficit/hyperactivity disorder (ADHD) is common among cocaine abusers seeking treatment. This open trial was carried out to assess the efficacy of sustained-release methylphenidate for the treatment of cocaine abuse among individuals with ADHD. Method: Twelve patients who met DSM-IV diagnostic criteria for adult ADHD and cocaine dependence were entered into-a 12-week trial of divided daily doses of sustained-release methylphenidate ranging from 40 to 80 mg. In addition to the pharmacotherapy, patients also received individual weekly relapse prevention therapy. Individuals were assessed weekly for ADHD symptoms; vital signs and urine toxicologies were obtained 3 times a week. Results: Of the 12 patients entered, 10 completed at least 8 weeks of the study and 8 completed the entire study. Using both a semistructured clinical interview and a self-report assessment, patients reported reductions in attention difficulties, hyperactivity, and impulsivity. Self-reported cocaine use and craving decreased significantly. More importantly, cocaine use, confined by urine toxicologies, also decreased significantly. Conclusion: These preliminary data suggest that under close supervision, the combined intervention of sustained-release methylphenidate and relapse prevention therapy may be effective in treating individuals with both adult ADHD and cocaine dependence.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 009018312

Download citation: RISBibTeXText

PMID: 9671342

Related references

An open-label pilot study of methylphenidate in the treatment of cocaine dependent patients with adult attention deficit/hyperactivity disorder. Journal of Addictive Diseases 23(1): 77-92, 2004

An open-label pilot study of methylphenidate in the treatment of cocaine-dependent patients with attention deficit hyperactivity disorder. Drug & Alcohol Dependence 60(Suppl 1): S208-S209, 1 December, 2000

Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment. Drug & Alcohol Dependence 52(1): 15-25, Sept 1, 1998

Methylphenidate treatment of cocaine abusers without attention deficit disorder: a negative report. American Journal of Drug and Alcohol Abuse 11(3-4): 193-197, 1985

Methylphenidate Discontinuation and Reinitiation during Long-Term Treatment of Children with Tourette's Disorder and Attention-Deficit Hyperactivity Disorder: A Pilot Study. Journal of Child and Adolescent Psychopharmacology 5(3): 205-214, 1995

Sleep in children with attention-deficit/hyperactivity disorder (ADHD) before and after 6-month treatment with methylphenidate: a pilot study. European Journal of Pediatrics 175(5): 695-704, 2016

Effects of methylphenidate treatment on the cerebellum in adult attention-deficit hyperactivity disorder: a magnetic resonance spectroscopy study. European Review for Medical and Pharmacological Sciences 21(2): 383-388, 2017

Brain biochemical effects of methylphenidate treatment using proton magnetic spectroscopy in youth with attention-deficit hyperactivity disorder: a controlled pilot study. Cns Neuroscience & Therapeutics 18(1): 34-40, 2012

Association of adult attention deficit hyperactivity disorder subtypes and response to methylphenidate HCL treatment: A magnetic resonance spectroscopy study. Neuroscience Letters 604: 188-192, 2015

Impact of attention-deficit hyperactivity disorder and other psychopathology on treatment retention among cocaine abusers in a therapeutic community. Addictive Behaviors 29(9): 1875-1882, 2004

How Informative Are Self-Reported Adult Attention-Deficit/Hyperactivity Disorder Symptoms? An Examination of the Agreement Between the Adult Attention-Deficit/Hyperactivity Disorder Self-Report Scale V1.1 and Adult Attention-Deficit/Hyperactivity Disorder Investigator Symptom Rating Scale. Journal of Child and Adolescent Psychopharmacology, 2017

Venlafaxine treatment of patients with comorbid alcohol/cocaine abuse and attention-deficit/hyperactivity disorder: a pilot study. Journal of Clinical Psychopharmacology 21(1): 116-118, 2001

Use of extended-release methylphenidate (concerta) in treatment of cocaine dependence in a patient presenting with attention deficit hyperactivity disorder. Journal of Neuropsychiatry and Clinical Neurosciences 26(3): E49-E50, 2015

A pilot study: differential effects of methylphenidate-OROS on working memory and attention functions in children with attention-deficit/hyperactivity disorder with and without behavioural comorbidities. Attention Deficit and Hyperactivity Disorders 3(1): 13-20, 2011

A pilot study of methylphenidate preference assessment in children diagnosed with attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology 15(5): 729-741, 2005